Caspase-independent type III PCD: a new means to modulate cell death in chronic lymphocytic leukemia.
Merle-Béral
H
H
Barbier
S
S
Roué
G
G
Bras
M
M
Sarfati
M
M
Susin
S A
SA
D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D051928:CD47 Antigen / Q000378:metabolism; D020169:Caspases / Q000378:metabolism*; D016923:Cell Death / Q000187:drug effects / Q000502:physiology*; D034281:Dynamins; D020558:GTP Phosphohydrolases / Q000378:metabolism; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000201:enzymology* / Q000473:pathology*; D008869:Microtubule-Associated Proteins / Q000378:metabolism; D024101:Mitochondrial Proteins / Q000378:metabolism
D051928:CD47 Antigen; C497894:CD47 protein, human; D008869:Microtubule-Associated Proteins; D024101:Mitochondrial Proteins; C025946:3-methyladenine; D020169:Caspases; D020558:GTP Phosphohydrolases; C110768:DNM1L protein, human; D034281:Dynamins; D000225:Adenine